Oatmeal, Colloidal
drugOn this page
Also known as Avena sativa (oat) kernel flourAvena sativa (oat) kernel mealAvena sativa grain hulledAvena sativa groatsColloidal oatmealOat flourOat grain hulledOat kernel flourOat kernel mealOatmealOatmeal powdercolloidal
Summary
Oatmeal, Colloidal (CHEMBL2109173) is a phase-3 clinical-stage unknown; indicated across 4 conditions including atopic eczema.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 4 conditions
- Clinical trials: 26
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2109173 |
| Name | Oatmeal, Colloidal |
| Type | Unknown |
| Max phase | 3 |
Also known as: Avena sativa (oat) kernel flour, Avena sativa (oat) kernel meal, Avena sativa grain hulled, Avena sativa groats, Colloidal oatmeal, Oat flour, Oat grain hulled, Oat kernel flour, Oat kernel meal, Oatmeal, Oatmeal powder, colloidal
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
4 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| atopic eczema | 2 | MONDO:0004980 | EFO:0000274 |
3 further indication records had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 26.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 18 |
| PHASE2 | 4 |
| PHASE1/PHASE2 | 3 |
| PHASE4 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05892081 | PHASE4 | COMPLETED | Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit |
| NCT03835767 | PHASE2 | RECRUITING | Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis |
| NCT01601522 | PHASE2 | COMPLETED | Peanut Allergy Oral Immunotherapy Desensitization |
| NCT01750879 | PHASE1/PHASE2 | COMPLETED | Tolerance Following Peanut Oral Immunotherapy |
| NCT01834352 | PHASE1/PHASE2 | WITHDRAWN | Walnut Oral Immunotherapy for Tree Nut Allergy |
| NCT01847053 | PHASE1/PHASE2 | COMPLETED | Bioavailability Study of Cinnamon in Healthy Subjects |
| NCT02103270 | PHASE2 | COMPLETED | The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery |
| NCT02575131 | PHASE2 | COMPLETED | Breakfast Test Products and Acute Satiety Scores |
| NCT00695461 | Not specified | COMPLETED | Lactobacillus Plantarum 299v in Colon Surgery |
| NCT01326910 | Not specified | COMPLETED | Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema |
| NCT02035150 | Not specified | COMPLETED | Effect of Different Fiber Breakfasts on Appetite and Weight Change in Overweight Subjects |
| NCT02181244 | Not specified | COMPLETED | Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects |
| NCT02480673 | Not specified | UNKNOWN | EFFECT OF Salvia Hispanica l. (CHIA) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS |
| NCT02616159 | Not specified | COMPLETED | Effect of Oatmeal Varieties on Glycemic and Insulinemic Responses in Healthy Individuals |
| NCT02651597 | Not specified | COMPLETED | A Study of the Effect of Oats on Post Prandial Glucose Response |
| NCT02691481 | Not specified | COMPLETED | Diabetes-Specific Nutritional Formulas Versus Oatmeal |
| NCT02818452 | Not specified | COMPLETED | Glycemic Impact of Oatmeal Plus OatWellXF28 |
| NCT03134079 | Not specified | COMPLETED | Influence on Food Liking of Adding Spices to Replace Dietary Sugar |
| NCT03139552 | Not specified | COMPLETED | Influence on Food Liking of Adding Spices to Replace Sugar Using CLT |
| NCT03165773 | Not specified | COMPLETED | Four-hour Glycemic Kinetic Response Following 13C-enriched Oatmeal Breakfast Compared to Hot Corn Grits |
| NCT03468179 | Not specified | COMPLETED | Oatmeal Effect on N-acyl-phosphatidylethanolamines |
| NCT03490851 | Not specified | COMPLETED | The Effect of a Breakfast Meal Containing Oat β-glucan on Food Intake at a Subsequent Meal in Normal-weight and Overweight Subjects |
| NCT04831892 | Not specified | COMPLETED | The Effect of Isosorbide Diesters Based Moisturizer on Skin Health |
| NCT05537649 | Not specified | COMPLETED | Glycemic Responses of an Innovative Oat Porridge |
| NCT06840574 | Not specified | SUSPENDED | The Effect of Nutritional Supplementation on Actinic Purpura: A Pilot Study |
| NCT07593105 | Not specified | COMPLETED | Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.